Anavex Life Sciences to Present at Oppenheimer 27th Annual Healthcare Conference
NEW YORK, March 15, 2017 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and …